472 related articles for article (PubMed ID: 38003230)
1. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
Zaripova LN; Midgley A; Christmas SE; Beresford MW; Pain C; Baildam EM; Oldershaw RA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003230
[TBL] [Abstract][Full Text] [Related]
2. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases.
Jasim SA; Yumashev AV; Abdelbasset WK; Margiana R; Markov A; Suksatan W; Pineda B; Thangavelu L; Ahmadi SH
Stem Cell Res Ther; 2022 Mar; 13(1):101. PubMed ID: 35255979
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications.
Huang Y; Wu Q; Tam PKH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077421
[TBL] [Abstract][Full Text] [Related]
4. Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration.
Li W; Xiang Z; Yu W; Huang X; Jiang Q; Abumansour A; Yang Y; Chen C
Stem Cell Res Ther; 2024 Feb; 15(1):34. PubMed ID: 38321524
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
Yang H; Cheong S; He Y; Lu F
Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells: ideal seeds for treating diseases.
Gao G; Fan C; Li W; Liang R; Wei C; Chen X; Yang Y; Zhong Y; Shao Y; Kong Y; Li Z; Zhu X
Hum Cell; 2021 Nov; 34(6):1585-1600. PubMed ID: 34272720
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.
Lee BW; Kwok SK
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373308
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications.
Li P; Ou Q; Shi S; Shao C
Cell Mol Immunol; 2023 Jun; 20(6):558-569. PubMed ID: 36973490
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.
Oh JY; Lee RH
Prog Retin Eye Res; 2021 Nov; 85():100967. PubMed ID: 33775824
[TBL] [Abstract][Full Text] [Related]
14. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():2938. PubMed ID: 30619298
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases.
Yang C; Wu M; You M; Chen Y; Luo M; Chen Q
Stem Cell Res Ther; 2021 Feb; 12(1):103. PubMed ID: 33541422
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
[TBL] [Abstract][Full Text] [Related]
19. Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Ren G; Chen X; Dong F; Li W; Ren X; Zhang Y; Shi Y
Stem Cells Transl Med; 2012 Jan; 1(1):51-8. PubMed ID: 23197640
[TBL] [Abstract][Full Text] [Related]
20. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
Chen Y; Yu Q; Hu Y; Shi Y
Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
